Our Research Publications
Updated August 2024
| Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
|---|---|---|---|---|---|---|
| Guideline No. 448: Prevention of Rh D Alloimmunization | Fung-Kee-Fung K, Wong K, Walsh J, Hamel C, Clarke G | 2024 | J Obstet Gynaecol Can | View Guideline No. 448: Prevention of Rh D Alloimmunization | Health care providers | Benchmarking and standard setting |
| Q&A: Restrictive or liberal transfusion strategy in myocardial infarction and anemia | Carson J, Callum J, Sztainert T | 2024 | Blood.ca website | View Q&A: Restrictive or liberal transfusion strategy in myocardial infarction and anemia | Health care providers | Benchmarking and standard setting |
| Transfusion Camp Rwanda 2023: A train-the-trainer workshop establishing locally driven leadership in knowledge translation and sustainability in transfusion medicine education | Nizeyimana F, Pendergrast J, Ntegerejuwampayee A, Lin Y, Kanyamuhunga A, Gashaija C, Masaisa F, Uzamukunda C, Mutuyimana G, Ndicunguye F, Gaseminari A, Mulindwa B, Muyombo T, Chargé S, Skelton T | 2024 | Vox Sang | View Transfusion Camp Rwanda 2023: A train-the-trainer workshop establishing locally driven leadership in knowledge translation and sustainability in transfusion medicine education | Health care providers | Education research |
| Comprendre l’immunité au Canada : études de séroprévalence de la COVID-19 | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Comprendre l’immunité au Canada : études de séroprévalence de la COVID-19 | General public | Other |
| Introducing a new blood product to better meet the transfusion needs of the Canadian Armed Forces | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Introducing a new blood product to better meet the transfusion needs of the Canadian Armed Forces | General public | Other |
| Immunoglobulin products | Harding SR, Cowan J, Jennings S | 2024 | Clinical Guide to Transfusion | View Immunoglobulin products | Health care providers | Benchmarking and standard setting |
| Management of Pregnancies Alloimmunized with Non-Rh and Non-K Alloantibodies | Jackson ME, Grabowska K, Lieberman L, Clarke G, Yan MTS, Canadian Obstetric Pediatric Transfusion N | 2024 | J Obstet Gynaecol Can | View Management of Pregnancies Alloimmunized with Non-Rh and Non-K Alloantibodies | Health care providers | Clinical research |
| FAQ : fin du Programme de dons dirigés de la Société canadienne du sang | Ning S | 2024 | Blood.ca website | View FAQ : fin du Programme de dons dirigés de la Société canadienne du sang | Health care providers | Benchmarking and standard setting |
| Comparative genome analyses of Staphylococcus aureus from platelet concentrates reveal rearrangements involving loss of type VII secretion genes | Ramirez-Arcos S, Ighem-Chi S, Flint A, Weedmark K, Pagotto F | 2024 | Access Microbiol | View Comparative genome analyses of Staphylococcus aureus from platelet concentrates reveal rearrangements involving loss of type VII secretion genes | Researchers | Basic research |
| Introduire un nouveau produit sanguin pour mieux répondre aux besoins transfusionnels des Forces armées canadiennes | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Introduire un nouveau produit sanguin pour mieux répondre aux besoins transfusionnels des Forces armées canadiennes | General public | Other |
| Prehospital Freeze-Dried Plasma in Trauma: A Critical Review | Sheffield WP, Singh K, Beckett A, Devine DV | 2024 | Transfus Med Rev | View Prehospital Freeze-Dried Plasma in Trauma: A Critical Review | Researchers | Benchmarking and standard setting |
| International review of blood donation nucleic acid amplification testing | Faddy HM, Osiowy C, Custer B, Busch M, Stramer SL, Adesina O, van de Laar T, Tsoi W-C, Styles C, Kiely P, Margaritis A, Kwon S-Y, Qiu Y, Deng X, Lewin A, Jørgensen SW, Erikstrup C, Juhl D, Sauleda S, Camacho Rodriguez BA, Coral LJCS, Gaviria García PA, Oota S, O'Brien SF, Wendel S, Castro E, Navarro Pérez L, Harvala H, Davison K, Reynolds C, Jarvis L, Grabarczyk P, Kopacz A, Łętowska M, O'Flaherty N, Young F, Williams P, Burke L, Chua SS, Muylaert A, Page I, Jones A, Niederhauser C, Vermeulen M, Laperche S, Gallian P, Sawadogo S, Satake M, Gharehbaghian A, Addas-Carvalho M, Blanco S, Gallego SV, Seltsam A, Weber-Schehl M, Al-Riyami AZ, Al Maamari K, Alawi FB, Pandey HC, Mbanya D, França RA, Charlewood R, the Virology Surveillance Risk Assessment Policy subgroups of the ISBT Working Party on Transfusion-transmitted Infectious Diseases | 2024 | Vox Sang | View International review of blood donation nucleic acid amplification testing | Blood operators | Benchmarking and standard setting |
| Comparative virulome analysis of four Staphylococcus epidermidis strains from human skin and platelet concentrates using whole genome sequencing | Yousuf B, Flint A, Weedmark K, Pagotto F, Ramirez-Arcos S | 2024 | Access Microbiol | View Comparative virulome analysis of four Staphylococcus epidermidis strains from human skin and platelet concentrates using whole genome sequencing | Researchers | Basic research |
| Making blood donation more inclusive with sexual behaviour-based screening for all donors | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Making blood donation more inclusive with sexual behaviour-based screening for all donors | General public | Other |
| Transforming research to improve therapies for trauma in the twenty-first century | Juffermans NP, Gözden T, Brohi K, Davenport R, Acker JP, Reade MC, Maegele M, Neal MD, Spinella PC | 2024 | Crit Care | View Transforming research to improve therapies for trauma in the twenty-first century | Researchers | New or improved product or process |
| Reconsidering Routine Repeat Group and Screens During Pregnancy-Personalizing Pregnancy Care | Tran A, Clarke G, Callum JL, Smith G, Somerset D, Thorne J, Lieberman L | 2024 | J Obstet Gynaecol Can | View Reconsidering Routine Repeat Group and Screens During Pregnancy-Personalizing Pregnancy Care | Health care providers | Clinical research |
| An international review of the characteristics of viral nucleic acid-amplification testing (NAT) reveals a trend towards the use of smaller pool sizes and individual donation NAT | Faddy HM, Osiowy C, Custer B, Busch M, Stramer SL, Dean MM, Acutt J, Viennet E, van de Laar T, Tsoi W-C, Styles C, Kiely P, Margaritis A, Kwon S-Y, Qiu Y, Deng X, Lewin A, Jørgensen SW, Erikstrup C, Juhl D, Sauleda S, Camacho Rodriguez BA, Soto Coral LJC, Gaviria García PA, Oota S, O'Brien SF, Wendel S, Castro E, Navarro Pérez L, Harvala H, Davison K, Reynolds C, Jarvis L, Grabarczyk P, Kopacz A, Łętowska M, O'Flaherty N, Young F, Williams P, Burke L, Chua SS, Muylaert A, Page I, Jones A, Niederhauser C, Vermeulen M, Laperche S, Gallian P, Satake M, Addas-Carvalho M, Blanco S, Gallego SV, Seltsam A, Weber-Schehl M, Al-Riyami AZ, Al Maamari K, Alawi FB, Pandey HC, França RA, Charlewood R, Virology t, Surveillance RA, Policy subgroups of the ISBT WP-TTID | 2024 | Vox Sang | View An international review of the characteristics of viral nucleic acid-amplification testing (NAT) reveals a trend towards the use of smaller pool sizes and individual donation NAT | Researchers | Benchmarking and standard setting |
| Renforcer l’inclusivité du don de sang : sélection basée sur les comportements sexuels pour tous les donneurs | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Renforcer l’inclusivité du don de sang : sélection basée sur les comportements sexuels pour tous les donneurs | General public | Other |
| Intravenous albumin in cardiac and vascular surgery: a systematic review and meta-analysis | Skubas NJ, Callum J, Bathla A, Keshavarz H, Fergusson D, Wu B, Stanworth S, Shehata N | 2024 | Br J Anaesth | View Intravenous albumin in cardiac and vascular surgery: a systematic review and meta-analysis | Health care providers | Benchmarking and standard setting |
| Normal Morphology and Physiology of Human Blood Including Main Clinical Parameters and Microscopy | Phan C, Brandon-Coatham M, Rahman A, Acker J | 2024 | The Optics of Blood: A Handbook | View Normal Morphology and Physiology of Human Blood Including Main Clinical Parameters and Microscopy | Researchers | Basic research |
| Prevalence of Hepatitis B in Canadian First-Time Blood Donors: Association with Social Determinants of Health | O’Brien SF, Ehsani-Moghaddam B, Goldman M, Drews SJ | 2024 | Viruses | View Prevalence of Hepatitis B in Canadian First-Time Blood Donors: Association with Social Determinants of Health | Researchers | Epidemiology research |
| Making IVIg treatment safer for patients | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Making IVIg treatment safer for patients | General public | Other |
| Restrictive or liberal transfusion strategy in myocardial infarction and anemia | Carson J | 2024 | Blood.ca website | View Restrictive or liberal transfusion strategy in myocardial infarction and anemia | Health care providers | Clinical research |
| Qualitative analysis of Canadian blood and plasma donors' views on expanding donor screening eligibility for gay, bisexual, and other men who have sex with men | Woo H, Fisher W, Kohut T, Haw J | 2024 | Transfusion | View Qualitative analysis of Canadian blood and plasma donors' views on expanding donor screening eligibility for gay, bisexual, and other men who have sex with men | Researchers | MSM Social science research |
| FAQ: Delisting of directed donations at Canadian Blood Services | Ning S | 2024 | Blood.ca website | View FAQ: Delisting of directed donations at Canadian Blood Services | Health care providers | Benchmarking and standard setting |
| SARS-CoV-2 seroprevalence in Nova Scotia blood donors | O'Brien SF, Deeks SL, Hatchette T, Pambrun C, Drews SJ | 2024 | J Assoc Med Microbiol Infect Dis Can | View SARS-CoV-2 seroprevalence in Nova Scotia blood donors | Researchers | Epidemiology research |
| Accuracy of venous thromboembolism ICD-10 codes: A systematic review and meta-analysis | Liu B, Hadzi-Tosev M, Eisa K, Liu Y, Lucier KJ, Garg A, Li S, Xu E, Mithoowani S, Ikesaka R, Heddle NM, Rochwerg B, Ning S | 2024 | Thromb Res | View Accuracy of venous thromboembolism ICD-10 codes: A systematic review and meta-analysis | Researchers | Basic research |
| Advancing gender inclusivity for Two-Spirit, trans, nonbinary and other gender-diverse blood and plasma donors | Haw J, Butler-Foster T, Murray B, Lapierre D, Bosse J, Edwards J, Gümüşpala Ş, Jenkins C, Devor A | 2024 | Vox Sang | View Advancing gender inclusivity for Two-Spirit, trans, nonbinary and other gender-diverse blood and plasma donors | Researchers | Social science research |
| Making platelet transfusions safer through pathogen reduction | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Making platelet transfusions safer through pathogen reduction | General public | Other |
| Commentary on "Inhibition of cellular activation induced by platelet factor 4 via the CXCR3 pathway ameliorates Japanese encephalitis and dengue viral infections" | Drews SJ | 2024 | J Thromb Haemost | View Commentary on "Inhibition of cellular activation induced by platelet factor 4 via the CXCR3 pathway ameliorates Japanese encephalitis and dengue viral infections" | Researchers | Epidemiology research |
| Comparable bacterial growth in platelet concentrates suspended in plasma and platelet additive solution and improved detection of bacterial contamination using a new generation automated culture system | Kou Y, Kumaran D, Howell A, Ramirez-Arcos S | 2024 | Transfusion | View Comparable bacterial growth in platelet concentrates suspended in plasma and platelet additive solution and improved detection of bacterial contamination using a new generation automated culture system | Researchers | Basic research |
| Reply to Kaestner et al.: Pioneering quantitative platforms for stored red blood cell assessment open the door for precision transfusion medicine | Isiksacan Z, D’Alessandro A, McKenna DH, Tessier SN, Kucukal E, Gokaltun AA, William N, Sandlin RD, Bischof J, Mohandas N, Busch MP, Elbuken C, Gurkan UA, Toner M, Acker JP, Yarmush ML, Usta OB | 2024 | PNAS | View Reply to Kaestner et al.: Pioneering quantitative platforms for stored red blood cell assessment open the door for precision transfusion medicine | Researchers | Benchmarking and standard setting |
| Alberta’s research priorities to advance organ donation and transplantation: an ecosystem-based and consensus-driven approach to strategic research planning | Davoodi S, Gongal P, Delaney S, Acker J, Boulet D, Boulet T, Dijke E, Elliot J, Halloran K, Halpin A, Hartell D, Kemp L, Kramer A, Lam N, Mager D, Mokoena T, Pepper A, Powell L, Tandon P, Wilson M, Wilkins R, Woolfsmith J, West L | 2024 | Can Heal Pol | View Alberta’s research priorities to advance organ donation and transplantation: an ecosystem-based and consensus-driven approach to strategic research planning | Researchers | Benchmarking and standard setting |
| Thrombotic triad in microgravity | Elahi MM, Witt AN, Pryzdial ELG, McBeth PB | 2024 | Thromb Res | View Thrombotic triad in microgravity | Researchers | Basic research |
| Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID-19 restriction in March 2020 | Drews SJ, Charlton C, O'Brien SF, Burugu S, Denomme GA | 2024 | Vox Sang | View Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID-19 restriction in March 2020 | Researchers | Epidemiology research |
| Homing and Engraftment of Hematopoietic Stem Cells Following Transplantation: A Pre-Clinical Perspective | Hasan T, Pasala AR, Hassan D, Hanotaux J, Allan DS, Maganti HB | 2024 | Curr Oncol | View Homing and Engraftment of Hematopoietic Stem Cells Following Transplantation: A Pre-Clinical Perspective | Researchers | Clinical research |
| Améliorer la sécurité des transfusions de plaquettes grâce à la réduction des agents pathogènes | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Améliorer la sécurité des transfusions de plaquettes grâce à la réduction des agents pathogènes | General public | Other |
| Determining the impact of current Canadian stem cell registry policy on donor availability via dynamic registry simulation | Blake JT, Ganz K, Seftel M, Allan D | 2024 | Vox Sang | View Determining the impact of current Canadian stem cell registry policy on donor availability via dynamic registry simulation | Blood operators | Benchmarking and standard setting |
| Améliorer la sécurité du sang en adoptant une approche fondée sur le risque pour la prise de décisions complexes | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Améliorer la sécurité du sang en adoptant une approche fondée sur le risque pour la prise de décisions complexes | General public | Other |
| Fournir des lignes directrices essentielles en temps de crise : soutien à la recherche sur la COVID-19 | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Fournir des lignes directrices essentielles en temps de crise : soutien à la recherche sur la COVID-19 | General public | Other |
| Reply to: "Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany" | Thompson LA, Charlton CL | 2024 | J Hepatol | View Reply to: "Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany" | Researchers | Epidemiology research |
| End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral | Lewin A, Goldman M, Busch MP, Davison K, van de Laar T, Tiberghien P, Shinar E, O'Brien SF, Lambert G, Field S, Hervig T, Tan DHS, Custer B, Drews SJ, Lanteri MC, Klochkov D, Widmer E, Domingue M-P, Renaud C, Germain M | 2024 | Vox Sang | View End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral | Researchers | Benchmarking and standard setting |
| Providing vital guidance in a time of crisis: COVID-19 research support | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Providing vital guidance in a time of crisis: COVID-19 research support | General public | Other |
| Impact of lower concentrations of dimethyl sulfoxide on cryopreservation of autologous hematopoietic stem cells: a systematic review and meta-analysis of controlled clinical studies | Bennett B, Hanotaux J, Pasala AR, Hasan T, Hassan D, Shor R, Allan DS, Maganti HB | 2024 | Cytotherapy | View Impact of lower concentrations of dimethyl sulfoxide on cryopreservation of autologous hematopoietic stem cells: a systematic review and meta-analysis of controlled clinical studies | Researchers | Benchmarking and standard setting |
| Post-Reconstitution Hemostatic Stability Profiles of Canadian and German Freeze-Dried Plasma | Peng HT, Moes K, Singh K, Rhind SG, Pambrun C, Jenkins C, da Luz L, Beckett A | 2024 | Life | View Post-Reconstitution Hemostatic Stability Profiles of Canadian and German Freeze-Dried Plasma | Researchers | Basic research |
| The effects of pen ink and surface disinfectants on red blood cells stored in plasticized polyvinylchloride transfusion bags | Uy RJ, Serrano K, Hadjesfandiari N, Shih AW, Devine D | 2024 | Transfusion | View The effects of pen ink and surface disinfectants on red blood cells stored in plasticized polyvinylchloride transfusion bags | Researchers | Basic research |
| Red cell concentrates from teen male donors contain poor-quality biologically older cells | Mykhailova O, Brandon-Coatham M, Phan C, Yazdanbakhsh M, Olafson C, Yi QL, Kanias T, Acker JP | 2024 | Vox Sang | View Red cell concentrates from teen male donors contain poor-quality biologically older cells | Researchers | Basic research |
| Améliorer la sécurité du traitement par IgIV pour les patients | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Améliorer la sécurité du traitement par IgIV pour les patients | General public | Other |
| Improving blood safety through a risk-informed approach to complex decision-making | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Improving blood safety through a risk-informed approach to complex decision-making | General public | Other |
| Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice | Won KD, Gil Gonzalez L, Cruz-Leal Y, Pavon Oro A, Lazarus AH | 2024 | J Immunol | View Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice | Researchers | Basic research |